Press Room

Oral and Inhalation Solid Dosage Forms Workshop

Start
Wednesday, March 27, 2019 - 00:00
End
Wednesday, March 27, 2019 - 00:00
Location: Switzerland
Oral Inhalation nasal Solid Dosage Forms | Hovione

 

Hovione is present at the Oral and Inhalation Solid Dosage Forms Workshop with a presentation by Maria Braga, Scientist of R&D Drug Product Development.

The workshop, organised at the MG2 premises on March Wednesday 27th, gives delegates the possibility to meet different industrial partners in a real market place; a place in which Academy and Industry can share their experiences and knowledge.

This event will last one day, divided in 2 different moments: speeches in the morning and workshop in the afternoon at MG2 Factory.

 

HOVIONE PRESENTATION

Title: From the engineered particle to lung deposition: how to successfully develop a carrier-based DPI?

Time: 9:30 am

Presenter: Maria Braga, Scientist of R&D Drug Product Development

 

 

If you would like to find more about Hovione's full range of inhalation drug development servicesparticle engineering and development by design schedule a meeting with us

Schedule a meeting button | Hovione

 

 

 

 

 

Also in the Press Room

See All

The global inhalation contract development and manufacturing organization (CDMO) market is projected to grow from USD 9.13 billion in 2025 to USD 16.68 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.7% during the forecast period. This growth is driven by the increasing prevalence of respiratory diseases, advancements in inhalation drug delivery technologies, and the rising demand for outsourced manufacturing services in the pharmaceutical industry. The inhalation CDMO market has emerged as a pivotal segment in the pharmaceutical contract development and manufacturing industry. With a rising demand for inhaled therapies for conditions like asthma, COPD, and cystic fibrosis, companies are increasingly outsourcing drug development and production to specialized partners. Inhalation CDMO services cater to both large pharmaceutical corporations and small biotech firms, offering expertise in formulation, device compatibility, regulatory support, and scale-up manufacturing. This market is gaining traction due to the complexity of inhalation drug delivery, which often requires niche technical capabilities and specialized equipment. Outsourcing to an inhalation CDMO allows drug developers to reduce time-to-market while ensuring quality and compliance with global standards. (...) Top Companies Several players dominate the inhalation CDMO market through technological expertise, global reach, and service portfolio diversity: (...) Hovione – Offers particle engineering and inhalation development, with a focus on dry powder inhalers. (...) These companies are continually investing in facilities, talent, and technology to meet evolving customer needs in the inhalation CDMO market.   Read the full article on Pharmiweb.com        

Press Clipping

Inhalation CDMO Market Growth Analysis & Forecast 2025 to 2035

Jun 25, 2025